Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

RITUXIMAB-ARRX vs ROFECOXIB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

RITUXIMAB-ARRX vs ROFECOXIB: Safety Overview

Metric RITUXIMAB-ARRX ROFECOXIB
Total FAERS Reports 347 1,238
Deaths Reported 11 56
Death Rate 3.2% 4.5%
Hospitalizations 21 176
Average Patient Age 57.0 yrs 63.1 yrs
% Female Patients 60.6% 77.9%
FDA Approval Date N/A Feb 25, 2000
Marketing Status Prescription Discontinued